Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) FCF Margin (2016 - 2026)

Ironwood Pharmaceuticals' FCF Margin history spans 16 years, with the latest figure at 156.31% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 13951.0% to 156.31% in Q4 2025 year-over-year; TTM through Dec 2025 was 42.89%, a 1346.0% increase, with the full-year FY2025 number at 42.89%, up 1346.0% from a year prior.
  • FCF Margin hit 156.31% in Q4 2025 for Ironwood Pharmaceuticals, up from 38.98% in the prior quarter.
  • Over the last five years, FCF Margin for IRWD hit a ceiling of 156.31% in Q4 2025 and a floor of 17.68% in Q2 2025.
  • Historically, FCF Margin has averaged 52.03% across 5 years, with a median of 51.72% in 2021.
  • The widest YoY moves for FCF Margin: up 13951bps in 2025, down -5307bps in 2025.
  • Tracing IRWD's FCF Margin over 5 years: stood at 55.02% in 2021, then soared by 34bps to 73.89% in 2022, then crashed by -59bps to 30.3% in 2023, then crashed by -45bps to 16.8% in 2024, then soared by 830bps to 156.31% in 2025.
  • Business Quant data shows FCF Margin for IRWD at 156.31% in Q4 2025, 38.98% in Q3 2025, and 17.68% in Q2 2025.